• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解码唾液非编码RNA组作为口腔癌检测和预后的新型生物标志物

Decoding Salivary ncRNAomes as Novel Biomarkers for Oral Cancer Detection and Prognosis.

作者信息

Das Subhadeep, Basak Sampad, Sarkar Soumyadev

机构信息

Department of Biochemistry, Purdue University, BCHM A343, 175 S. University Street, West Lafayette, IN 47907-2063, USA.

Purdue University Institute for Cancer Research, Purdue University, Hansen Life Sciences Research Building, Room 141, 201 S. University Street, West Lafayette, IN 47907-2064, USA.

出版信息

Noncoding RNA. 2025 Mar 20;11(2):28. doi: 10.3390/ncrna11020028.

DOI:10.3390/ncrna11020028
PMID:40126352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11932315/
Abstract

Oral cancer (OC) ranks among the most prevalent head and neck cancers, becoming the eleventh most common cancer worldwide with ~350,000 new cases and 177,000 fatalities annually. The rising trend in the occurrence of OC among young individuals and women who do not have tobacco habits is escalating rapidly. Surgical procedures, radiation therapy, and chemotherapy are among the most prevalent treatment options for oral cancer. To achieve better therapy and an early detection of the cancer, it is essential to understand the disease's etiology at the molecular level. Saliva, the most prevalent body fluid obtained non-invasively, holds a collection of distinct non-coding RNA pools (ncRNAomes) that can be assessed as biomarkers for identifying oral cancer. Non-coding signatures, which are transcripts lacking a protein-coding function, have been identified as significant in the progression of various cancers, including oral cancer. This review aims to examine the role of various salivary ncRNAs (microRNA, circular RNA, and lncRNA) associated with disease progression and to explore their functions as potential biomarkers for early disease identification to ensure better survival outcomes for oral cancer patients.

摘要

口腔癌(OC)是最常见的头颈癌之一,成为全球第十一大常见癌症,每年约有35万新发病例和17.7万例死亡。在无吸烟习惯的年轻人和女性中,OC发病率的上升趋势正在迅速加剧。手术、放疗和化疗是口腔癌最常见的治疗选择。为了实现更好的治疗和癌症的早期检测,在分子水平上了解该疾病的病因至关重要。唾液是最容易通过非侵入性获得的体液,含有一系列独特的非编码RNA库(ncRNAome),可作为识别口腔癌的生物标志物进行评估。非编码特征是缺乏蛋白质编码功能的转录本,已被确定在包括口腔癌在内的各种癌症进展中具有重要意义。本综述旨在研究各种唾液ncRNA(微小RNA、环状RNA和长链非编码RNA)与疾病进展相关的作用,并探索它们作为早期疾病识别潜在生物标志物的功能,以确保口腔癌患者有更好的生存结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11932315/7f8fd6c74828/ncrna-11-00028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11932315/00aebede7db7/ncrna-11-00028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11932315/ca08d3030f5c/ncrna-11-00028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11932315/b7bb16100efc/ncrna-11-00028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11932315/7f8fd6c74828/ncrna-11-00028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11932315/00aebede7db7/ncrna-11-00028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11932315/ca08d3030f5c/ncrna-11-00028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11932315/b7bb16100efc/ncrna-11-00028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c345/11932315/7f8fd6c74828/ncrna-11-00028-g004.jpg

相似文献

1
Decoding Salivary ncRNAomes as Novel Biomarkers for Oral Cancer Detection and Prognosis.解码唾液非编码RNA组作为口腔癌检测和预后的新型生物标志物
Noncoding RNA. 2025 Mar 20;11(2):28. doi: 10.3390/ncrna11020028.
2
Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications.口腔癌中的非编码RNA:新兴作用与临床应用
Cancers (Basel). 2023 Jul 25;15(15):3752. doi: 10.3390/cancers15153752.
3
Emerging cell cycle related non-coding RNA biomarkers from saliva and blood for oral squamous cell carcinoma.唾液和血液中与细胞周期相关的新兴非编码 RNA 生物标志物用于口腔鳞状细胞癌。
Mol Biol Rep. 2023 Nov;50(11):9479-9496. doi: 10.1007/s11033-023-08791-w. Epub 2023 Sep 17.
4
Salivaomics to decode non-coding RNAs in oral cancer. A narrative review.唾液组学解码口腔癌中的非编码RNA:一项叙述性综述
Noncoding RNA Res. 2023 May 13;8(3):376-384. doi: 10.1016/j.ncrna.2023.05.001. eCollection 2023 Sep.
5
Noncoding RNAs in oral cancer.口腔癌中的非编码 RNA。
Wiley Interdiscip Rev RNA. 2023 May-Jun;14(3):e1754. doi: 10.1002/wrna.1754. Epub 2022 Aug 12.
6
Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.唾液细胞因子作为口腔癌生物标志物的系统评价和荟萃分析。
BMC Cancer. 2021 Feb 27;21(1):205. doi: 10.1186/s12885-021-07932-3.
7
Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer.唾液作为一种潜在的非侵入性液体活检手段,用于头颈部癌症的早期简易诊断/预后评估。
Transl Oncol. 2024 Feb;40:101827. doi: 10.1016/j.tranon.2023.101827. Epub 2023 Dec 2.
8
Salivary Biomarkers for Oral Cancer Detection: Insights from Human DNA and RNA Analysis.唾液生物标志物在口腔癌检测中的应用:基于人类 DNA 和 RNA 分析的研究进展。
Cardiovasc Hematol Agents Med Chem. 2024;22(3):249-257. doi: 10.2174/0118715257269271231201094946.
9
Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics.非编码RNA在卵巢癌预后和治疗中的最新进展
Ther Adv Med Oncol. 2022 Aug 12;14:17588359221118010. doi: 10.1177/17588359221118010. eCollection 2022.
10
Molecular and Therapeutic Roles of Non-Coding RNAs in Oral Cancer-A Review.非编码 RNA 在口腔癌中的分子和治疗作用——综述
Molecules. 2024 May 20;29(10):2402. doi: 10.3390/molecules29102402.

本文引用的文献

1
Identification of common salivary miRNA in oral lichen planus and oral squamous cell carcinoma: systematic review and meta-analysis.口腔扁平苔藓和口腔鳞状细胞癌中常见唾液 miRNA 的鉴定:系统评价和荟萃分析。
BMC Oral Health. 2024 Oct 4;24(1):1177. doi: 10.1186/s12903-024-04986-0.
2
Expression Analysis of Circulating microRNAs in Saliva and Plasma for the Identification of Clinically Relevant Biomarkers for Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.唾液和血浆中循环微小RNA的表达分析,用于鉴定口腔鳞状细胞癌和口腔潜在恶性疾病的临床相关生物标志物。
Cancers (Basel). 2024 Aug 28;16(17):2990. doi: 10.3390/cancers16172990.
3
Oral microbiome and its relationship with oral cancer.
口腔微生物组及其与口腔癌的关系。
J Cancer Res Ther. 2024 Aug 1;20(4):1141-1149. doi: 10.4103/jcrt.jcrt_44_24. Epub 2024 Aug 29.
4
Biomarkers for Oral Squamous Cell Carcinoma (miR-24, miR-200, and miR-34): Screening and Detection MicroRNA.口腔鳞状细胞癌生物标志物 (miR-24、miR-200 和 miR-34):miRNA 的筛选和检测。
Asian Pac J Cancer Prev. 2024 Jul 1;25(7):2265-2269. doi: 10.31557/APJCP.2024.25.7.2265.
5
Downregulation of salivary miR-3928 as a potential biomarker in patients with oral squamous cell carcinoma and oral lichen planus.下调唾液 miR-3928 作为口腔鳞状细胞癌和口腔扁平苔藓患者的潜在生物标志物。
Clin Exp Dent Res. 2024 Apr;10(2):e877. doi: 10.1002/cre2.877.
6
"Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".“唾液 LINC00657 和 miRNA-106a 作为口腔鳞状细胞癌的诊断生物标志物,一项观察性诊断研究”。
BMC Oral Health. 2023 Dec 12;23(1):994. doi: 10.1186/s12903-023-03726-0.
7
The emerging role of oral microbiota in oral cancer initiation, progression and stemness.口腔微生物群在口腔癌发生、发展和干性中的新兴作用。
Front Immunol. 2023 Oct 26;14:1198269. doi: 10.3389/fimmu.2023.1198269. eCollection 2023.
8
Emerging cell cycle related non-coding RNA biomarkers from saliva and blood for oral squamous cell carcinoma.唾液和血液中与细胞周期相关的新兴非编码 RNA 生物标志物用于口腔鳞状细胞癌。
Mol Biol Rep. 2023 Nov;50(11):9479-9496. doi: 10.1007/s11033-023-08791-w. Epub 2023 Sep 17.
9
MALAT1 as a potential salivary biomarker in oral squamous cell carcinoma through targeting miRNA-124.MALAT1 作为一种潜在的唾液生物标志物,通过靶向 miRNA-124 在口腔鳞状细胞癌中发挥作用。
Oral Dis. 2024 May;30(4):2075-2083. doi: 10.1111/odi.14730. Epub 2023 Sep 13.
10
Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications.口腔癌中的非编码RNA:新兴作用与临床应用
Cancers (Basel). 2023 Jul 25;15(15):3752. doi: 10.3390/cancers15153752.